US › Healthcare

Curis Inc (CRIS)

US · Healthcare · Biotechnology

$0.41-19.61%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-8.6M

EPS

$-4.02

EPS estimate

$-5.70

EPS came in at -4.02 against a street estimate of -5.70 — a beat of 29.5%.

Key statistics

Market cap

$1.5M

P/E

0.5

Forward P/E

0.0

P/B

0.56

Book value

$2.41

EPS (TTM)

$1.32

52-week high

$33.60

52-week low

$0.57

50-day MA

$1.61

200-day MA

$10.35

Beta

3.10

Analyst view

Analysts rate Curis Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $42.67.

Shareholding

Insiders

6.46%

Institutions

29.05%

Largest institutional holders

Fund	Stake
Stonepine Capital Management Llc	7.92%
Nantahala Capital Management, LLC	4.73%
Cable Car Capital LLC	3.19%
CM Management, LLC	1.32%
Morgan Stanley - Brokerage Accounts	1.21%
Vanguard Capital Management, LLC	0.82%
Geode Capital Management, LLC	0.70%
M28 Capital Management LP	0.68%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Curis Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.